Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL10729902 | 0.97 | TSHR (0.53) | TSHRNAPRTTDP1MEN1KMT2A | |
| Pyridine SCHEMBL545571 | 0.97 | TSHR (0.53) | TSHRNAPRTTDP1MEN1KMT2A | |
| Pyridine SCHEMBL1097936 | 0.90 | TSHR (0.45) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL6702223 | 0.87 | TSHR (0.43) | TSHRNAPRTTDP1 | |
| Hexane SCHEMBL11381748 | 0.87 | TDP1 (0.43) | TSHRNAPRTTDP1MEN1KMT2A | |
| Pyridine SCHEMBL27766347 | 0.85 | TSHR (0.41) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL28162725 | 0.84 | TSHR (0.39) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL7121434 | 0.82 | TSHR (0.43) | TSHRNAPRTTDP1 | |
| Pyrazine SCHEMBL2492066 | 0.82 | ALDH1A1 (0.33) | KMT2A | |
| Pyridine SCHEMBL9246212 | 0.82 | LMNA (0.50) | TSHRNAPRTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629280-B2 | Methods for oligomerizing olefins with chromium pyridine ether catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-01-14 | — | — | US | disclosed |
| EP-2114974-A1 | METHODS FOR OLIGOMERIZING OLEFINS WITH CHROMIUM PYRIDINE ETHER CATALYSTS | ExxonMobil Chemical Patents Inc. (US) | 2009-11-11 | — | — | EP | disclosed |
| EP-2114974-A1 | METHODS FOR OLIGOMERIZING OLEFINS WITH CHROMIUM PYRIDINE ETHER CATALYSTS | ExxonMobil Chemical Patents Inc. (US) | 2009-11-11 | — | — | EP | disclosed |
| US-20080200743-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Ether Catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-08-21 | — | — | US | disclosed |
| WO-2008085659-A1 | METHODS FOR OLIGOMERIZING OLEFINS WITH CHROMIUM PYRIDINE ETHER CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008085659-A1 | METHODS FOR OLIGOMERIZING OLEFINS WITH CHROMIUM PYRIDINE ETHER CATALYSTS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200743-A1 | Methods For Oligomerizing Olefins With Chromium Pyridine Ether Catalysts | OXER1, NOD1, NOD2 | TSHR 2792/4885NAPRT 1014/4885TDP1 641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.